Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821825-24-000108
Filing Date
2024-11-01
Accepted
2024-11-01 08:06:35
Documents
85
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ogn-20240930.htm   iXBRL 10-Q 1603161
2 EX-31.1 ogn09302024-exhibit311.htm EX-31.1 8973
3 EX-31.2 ogn09302024-exhibit312.htm EX-31.2 9122
4 EX-32.1 ogn09302024-exhibit321.htm EX-32.1 6712
5 EX-32.2 ogn09302024-exhibit322.htm EX-32.2 6498
  Complete submission text file 0001821825-24-000108.txt   8661582

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogn-20240930.xsd EX-101.SCH 54546
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ogn-20240930_cal.xml EX-101.CAL 55874
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ogn-20240930_def.xml EX-101.DEF 251703
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogn-20240930_lab.xml EX-101.LAB 662978
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogn-20240930_pre.xml EX-101.PRE 464998
87 EXTRACTED XBRL INSTANCE DOCUMENT ogn-20240930_htm.xml XML 1662467
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40235 | Film No.: 241417125
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)